1983
DOI: 10.1152/ajpgi.1983.245.5.g601
|View full text |Cite
|
Sign up to set email alerts
|

Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms

Abstract: Recent evidence indicates that prostaglandins (PGs) possess potent gastric antiulcer properties independent of their known inhibitory effects on acid secretion. The mechanism underlying this cytoprotective property, as it has been called, has remained elusive. Although exogenously administered PGs can prevent disruption of the gastric mucosal barrier, enhance gastric mucosal blood flow, and stimulate mucus and bicarbonate secretion, as well as a number of cellular transport processes, evidence for and against … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
242
0
2

Year Published

1985
1985
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 374 publications
(255 citation statements)
references
References 124 publications
11
242
0
2
Order By: Relevance
“…These non-proteic compounds are important for maintaining the integrity of the gastric mucosa. Endogenous sulfhydryl compounds mediate the protective effects of prostaglandins against gastric mucosal injury (Miller 1983). Potentiation of the mucosal injury by NEM, an SH blocker, may be explained by the enhanced microvascular permeability in the gastric mucosa and inhibition of the gastric motility commonly associated with the prevention of mucosal injury (Takeuchi et al 1989).…”
Section: Resultsmentioning
confidence: 99%
“…These non-proteic compounds are important for maintaining the integrity of the gastric mucosa. Endogenous sulfhydryl compounds mediate the protective effects of prostaglandins against gastric mucosal injury (Miller 1983). Potentiation of the mucosal injury by NEM, an SH blocker, may be explained by the enhanced microvascular permeability in the gastric mucosa and inhibition of the gastric motility commonly associated with the prevention of mucosal injury (Takeuchi et al 1989).…”
Section: Resultsmentioning
confidence: 99%
“…PGE2 exerts a number of biological actions on the stomach including inhibition of acid secretion, stimulation of HCO3-and mucus secretion and vasodilation of the gastric vasculature (Miller, 1983). Since specific PGE2 binding was detected in each fraction it is possible that these biological actions are initiated even by small degrees of PGE2 binding to the cells regulating these actions.…”
Section: Discussionmentioning
confidence: 99%
“…These studies have also been done using a stable analogue of prostacyclin or PGI2 (Iloprost). Both PGE2 and PGI2 have been detected in gastric mucosa of a number of animals (Robert, 1981;Miller, 1983) and administration of PGE2, PGI2 or Iloprost exert potent biological action on the stomachs of a number of animals and humans (Vischer & Casals-Stenzel, 1982;Miller, 1983). Furthermore this laboratory has characterized the binding of both prostanoids using gastric tissue from a number of species (Tepperman & Soper, 1981Tepperman, Soper & Emery, 1984).…”
Section: Introductionmentioning
confidence: 99%
“…nism (20)(21)(22), but these effects are not without controversy (23,24). Mersereau and Hinchey (25) proposed that dissolution of the mucosal folds may be associated with the prevention of necrotic gastric lesions along the fold crests in the stomach after exposure to necrotizing agents.…”
Section: Discussionmentioning
confidence: 99%